LATEST
Kazia Therapeutics Limited (KZIA) Discusses Clinical and Corporate Updates With Focus on Paxalisib Programs in Breast and Colorectal Cancer Transcript✦Sabato: RNC Convention Unlikely to Move Midterm Needle✦Rob Hunt Column: Parents supply another teachable sportsmanship moment✦Zero FIR In Bengaluru Against Uttarakhand BJP State President Over ‘Purification’ Ritual✦Weaknesses for Texas, A&M's QB sounds off and 2026 dark horses | A Texas take on college football✦
Fri, Sep 4, 2026
Loading weather...
Business

Entravision director Paul Zevnik sells $293,964 in stock

By Dhallo News · September 5, 2026 at 3:30 AM IST

More details on this developing story will follow.

SOURCE: Investing.com - News
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Business

Kazia Therapeutics Limited (KZIA) Discusses Clinical and Corporate Updates With Focus on Paxalisib Programs in Breast and Colorectal Cancer Transcript

Breaking News......

Read Article »

Sabato: RNC Convention Unlikely to Move Midterm Needle

Larry Sabato, founder and director of the University of Virginia Center for Poli...

Read Article »

Flow Traders: Growth Strategy Remains Too Cautious

Breaking News......

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.